4//SEC Filing
Larkin Finbar 4
Accession 0001765581-20-000043
CIK 0001232524other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 6:06 PM ET
Size
6.6 KB
Accession
0001765581-20-000043
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2020-03-06$119.15/sh−292$34,793→ 14,498 total - Sale
Ordinary Shares
2020-03-09$111.49/sh−615$68,566→ 13,883 total
Footnotes (2)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $111.4701 to $111.5101. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001793243
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 6:06 PM ET
- Size
- 6.6 KB